Piramal Pharma Ltd
Board Meeting Intimation for Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
06:44 PM, 13th Jan 2025
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2024
